Last reviewed · How we verify

Midodrine Hydrochloride Tablets

Tehran Heart Center · Phase 3 active Small molecule

Midodrine is an alpha-1 adrenergic agonist that increases blood pressure by constricting blood vessels.

Midodrine is an alpha-1 adrenergic agonist that increases blood pressure by constricting blood vessels. Used for Orthostatic hypotension, Symptomatic hypotension.

At a glance

Generic nameMidodrine Hydrochloride Tablets
Also known asGutron
SponsorTehran Heart Center
Drug classAlpha-1 adrenergic agonist
TargetAlpha-1 adrenergic receptor
ModalitySmall molecule
Therapeutic areaCardiovascular
PhasePhase 3

Mechanism of action

Midodrine is a prodrug that is metabolized to desglymidodrine, its active metabolite, which selectively stimulates alpha-1 adrenergic receptors on arterioles and venules. This peripheral vasoconstriction increases both systolic and diastolic blood pressure, making it useful for treating conditions characterized by abnormally low blood pressure. The drug does not cross the blood-brain barrier significantly, limiting central nervous system effects.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results